A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice

Oncotarget

Volumn 8, Issue 1, 2017, Pages 610-623

  Wang, Jinglin ^a   Li, Weiyong ^a   Huang, Xiao ^a   Liu, Ying ^c   Li, Qiang ^a   Zheng, Ziming ^a   Wang, Kaiping ^b  

^a UNION HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Colon cancer; Lentinan; Nude mice; ROS

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ACETYLCYSTEINE; ACRIDINE ORANGE; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 9; CYTOCHROME C; EOSIN; ETHIDIUM BROMIDE; FLUORESCEIN ISOTHIOCYANATE; FLUOROURACIL; FUNGAL POLYSACCHARIDE; HEMATOXYLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTINULA EDODES EXTRACT; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SLNT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; WATER; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; FRUITING BODY; HT-29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROPIDIUM IODIDE ASSAY; TUMOR GROWTH; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; GENETICS; LENTINULA EDODES; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FUNGAL POLYSACCHARIDES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SHIITAKE MUSHROOMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85009818965     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.13481     Document Type: Article

References (38)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer Statistics, 2005. CA-Cancer J Clin. 2005; 55:10-30.
2. Lin J, Qiu M, Xu R, Sandra Dobs A. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database. Oncotarget. 2015; 6:33935-43. doi: 10.18632/oncotarget.5223.
3. Wolpin BM, Mayer RJ. Systemic Treatment of Colorectal Cancer. Gastroenterology. 2008; 134:1296-1310.e1291.
4. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004; 22:23-30.
5. Chau I, Cunningham D. Adjuvant therapy in colon cancer-what, when and how? Ann Oncol. 2006; 17: 1347-1359.
6. Bisen PS, Baghel RK, Sanodiya BS, Thakur GS, Prasad GBKS. Lentinus edodes: A Macrofungus with Pharmacological Activities. Curr Med Chem. 2010; 17:2419-2430.
7. Shida M, Haryu K, Matsuda K. On the water-soluble heterogalactan from the fruit bodies of lentinus edodes. Carbohydrate Res. 1975; 41:211-218.
8. Wasser S. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biot. 2002; 60:258-274.
9. Kenji I, Takae K, Takafumi A. The Use of Lentinan for Treating Gastric Cancer. Anti-Cancer Agent Me. 2013; 13:681-688.
10. Maeda YY, Watanabe ST, Chihara C, Rokutanda M. Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses. Cancer Res. 1988; 48:671-675.
11. Wang KP, Zhang QL, Liu Y, Wang J, Cheng Y, Zhang Y. Structure and inducing tumor cell apoptosis activity of polysaccharides isolated from Lentinus edodes. J Agr Food Chem. 2013; 61:9849-9858.
12. Gu YH, Belury MA. Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes. Cancer Lett. 2005; 220:21-28.
13. Israilides C, Kletsas D, Arapoglou D, Philippoussis A, Pratsinis H, Ebringerova A, Hribalova V, Harding SE. In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine. 2008; 15:512-519.
14. Wang K-p, Wang J, Li Q, Zhang Q-l, You R-x, Cheng Y, Luo L, Zhang Y. Structural differences and conformational characterization of five bioactive polysaccharides from Lentinus edodes. Food Res Int. 2014; 62:223-232.
15. Zhang Y, Li Q, Shu Y, Wang H, Zheng Z, Wang J, Wang K. Induction of apoptosis in S180 tumour bearing mice by polysaccharide from Lentinus edodes via mitochondria apoptotic pathway. J Funct Foods. 2015; 15:151-159.
16. Butler LM, Hewett PJ, Fitridge RA, Cowled PA. Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. Aust Nz J Surg. 1999; 69:88-94.
17. Rupnarain C, Dlamini Z, Naicker S, Bhoola K. Colon cancer: genomics and apoptotic events. Bio Chem. 2004; 449.
18. Watson AJM, Merritt AJ, Jones LS, Askew JN, Anderson E, Becciolini A, Balzi M, Potten CS, Hickman JA. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer. 1996; 73:889-895.
19. Ding HF, Fisher DE. Induction of apoptosis in cancer: new therapeutic opportunities. Ann Med. 2002; 34:451-469.
20. Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ. 2015; 22:526-539.
21. Hengartner MO. The biochemistry of apoptosis. Nature. 2000; 407:770-776.
22. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012; 19:107-120.
23. Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol. 2007; 35:495-516.
24. Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH. Screening and detection of apoptosis. J Surg Res. 2007; 139:143-156.
25. Reis FS, Sousa D, Barros L, Martins A, Morales P, Ferreira IC, Vasconcelos MH. Leccinum vulpinum Watling induces DNA damage, decreases cell proliferation and induces apoptosis on the human MCF-7 breast cancer cell line. Food Chem Toxicol. 2016; 90:45-54.
26. Shao FY, Du ZY, Ma DL, Chen WB, Fu WY, Ruan BB, Rui W, Zhang JX, Wang S, Wong NS, Xiao H, Li MM, Liu X, et al. B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy. Oncotarget. 2015; 6:30939-56. doi: 10.18632/oncotarget.5132.
27. Adams JM, Cory S. The Bcl-2 Protein Family: Arbiters of Cell Survival. Science. 1998; 281:1322-1326.
28. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 Family Reunion. Mol Cell. 2010; 37:299-310.
29. Lavik AR, Zhong F, Chang M-J, Greenberg E, Choudhary Y, Smith MR, McColl KS, Pink J, Reu FJ, Matsuyama S, Distelhorst CW. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015; 6:27388-402. doi: 10.18632/oncotarget.4489.
30. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Bio Med. 2010; 48:749-762.
31. Zou P, Chen M, Ji J, Chen W, Chen X, Ying S, Zhang J, Zhang Z, Liu Z, Yang S, Liang G. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer. Oncotarget. 2015; 6:36505-21. doi: 10.18632/oncotarget.5364.
32. Wang L, Tian Z, Yang Q, Li H, Guan H, Shi B, Hou P, Ji M. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. Oncotarget. 2015; 6:25917-31. doi: 10.18632/oncotarget.4542.
33. Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 2016; 44:221-231.
34. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9:361-371.
35. Karin M, Lin A. NF-[kappa]B at the crossroads of life and death. Nat Immunol. 2002; 3:221-227.
36. Maeda YY, Chihara G. The effects of neonatal thymectomy on the antitumour activity of lentinan, carboxymethylpachymaran and zymosan, and their effects on various immune responses. Int J Cancer. 1973; 11:153-161.
37. Guichard S, Cussac D, Hennebelle I, Bugat R, Canal P. Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo. Int J Cancer. 1997; 73:729-734.
38. Wang GF, Wu SY, Xu W, Jin H, Zhu ZG, Li ZH, Tian YX, Zhang JJ, Rao JJ, Wu SG. Geniposide inhibits high glucoseinduced cell adhesion through the NF-kappaB signaling pathway in human umbilical vein endothelial cells. Acta Pharmacol Sin. 2010; 31:953-962.